Mycoplasma pneumoniae, the bacterium best known for causing walking pneumonia, increased sharply among young U.S. children in 2024. Most infections remain confined to the chest and resolve without complication. Researchers, however, have been documenting a broader range of rare brain and nerve complications associated with the germ, and a case from Japan adds one of the most unusual examples.

A 4-year-old boy began seeing human faces, ears, and hair as stretched a few days after recovering from an upper respiratory infection. Blood tests showed elevated antibodies to M. pneumoniae. Doctors at Tokyo Medical University diagnosed prosopometamorphopsia, a rare disorder in which faces appear distorted even though the eyes function normally.

The report, published Feb. 3, 2026, in Cureus, joins larger studies, including one that identified an unusual cluster of serious brain complications in children during the most recent global wave.

One Child’s Distorted Faces and an Antibody Clue

The boy’s eye exam, brain MRI, blood vessel imaging, and EEG were all normal, and his visual acuity was excellent. His IQ tested at 123. The only abnormal result was an M. pneumoniae antibody level of 1:160. After a year of follow-up, the distortions had neither worsened nor faded, and his development remained normal.

The authors believe this is the first reported case of the disorder beginning in early childhood, with infection as a possible trigger. They hypothesized that an autoimmune or inflammatory response after exposure to the bacterium may have disrupted the brain network that processes faces.

They were candid about the limitations. The antibody elevation was mild and does not prove that the infection caused the symptoms. Prosopometamorphopsia itself is extremely rare: a 2021 review in Cortex analyzed 81 cases, including 73 published over the previous century.

The Tokyo authors pointed to one related precedent. A 7-year-old girl had previously been reported with Alice in Wonderland syndrome after M. pneumoniae infection, perceiving her mother’s face, fingers, and other objects as smaller than they were.

A Bacterium With Reach Beyond the Lungs

Brain involvement after M. pneumoniae is not new. A 1993 analysis by Marjaleena Koskiniemi of the University of Helsinki estimated that central nervous system problems appear in about 1 of every 1,000 patients with the infection.

A review published June 4, 2026, in Open Forum Infectious Diseases pulled together 207 published cases from 2015 to 2025. Patients ranged in age from 3 to 69. Encephalitis, or brain inflammation, accounted for 72% of cases. Most patients received antibiotics, and 81% recovered completely. As in the Tokyo case, most diagnoses rested mainly on antibody tests in the blood.

Adults are affected too. Among 1,309 adults hospitalized with the infection during France’s 2023 to 2024 epidemic, 28, or 2.1%, had neurological complications attributed to it, according to a multicenter study published in July 2026.

The 2024 Wave and a Cluster in South Korea

In the U.S., the CDC identified a rise in M. pneumoniae infections in 2024, with a notable increase in children ages 2 to 4, a group the bacterium historically affected less than school-age children. Emergency department visits peaked in August 2024. The agency says infections in children under 5 were not more severe than in earlier years and have been declining since the beginning of 2025, though they remained elevated in some regions into 2026. There is no national reporting system for the infection.

South Korea saw something unexpected during the same wave. A study in the CDC journal Emerging Infectious Diseases identified 17 children with M. pneumoniae-associated encephalitis or stroke at three hospitals from October 2023 through December 2024. Their median age was 8.8. Twelve had encephalitis, and five had ischemic strokes. Four had no respiratory symptoms beforehand, and seven needed intensive care. Their hospital stays ran a median of 29 days, compared with 6 days for children hospitalized with the infection but no brain involvement.

No deaths were reported. At last follow-up, 83.3% of children with encephalitis and 60% of those with stroke had no or mild disability. Similar clustering was not seen in earlier seasons, but the researchers could not determine whether the pattern reflected better detection, greater awareness, or a true change in the disease. They raised a possible immunity gap left by pandemic-era suppression of respiratory germs.

Taking Unusual Complaints Seriously

These complications remain rare, and most children with M. pneumoniae recover without any neurological problems. Because many diagnoses depend on blood antibody tests, it is often difficult to prove that the bacterium caused any single case.

The Tokyo pediatricians urged clinicians to take children’s complaints about strange perceptions seriously and to “avoid dismissing them as imagination or play.” Young children may struggle to describe what they see, which is why this boy’s drawings proved so useful.

Parents should seek urgent care if a child develops seizures, confusion, unusual sleepiness, weakness, or a sudden change in behavior during or after a respiratory illness. Visual distortions that persist deserve evaluation by a pediatrician.

Key Questions Answered

What happened to the boy in Japan?

After an upper respiratory infection, a 4-year-old began seeing faces, ears, and hair as stretched. Tests showed antibodies to M. pneumoniae.

Did the bacterium cause his symptoms?

That is not proven. Doctors suspect an immune reaction, but the antibody rise was mild and does not establish cause.

How often does M. pneumoniae affect the brain?

Rarely. A 1993 estimate put central nervous system problems at about 1 in 1,000 infections.

What brain complications are most common?

Encephalitis accounted for 72% of 207 cases in a 2026 review, and 81% of patients recovered completely.

Is M. pneumoniae still circulating in the U.S.?

The CDC says infections have declined since early 2025 but remained elevated in some regions into 2026.

Source link

Exit mobile version